source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Yahoo | 2020-08-19 13:59:19 | https://finance.yahoo.com/m/de82d955-19b6-3ecf-8ee4-e9cd0b8dab59/dow-jones-today%2C-stocks.html | Target and United Airlines staked early leads as financials led the Dow Jones today, but stocks struggled in mixed trade. | Dow Jones Today, Stocks Mixed; Target Heads Retail Rally; Biotechs Momenta, Gilead, Biomarin Swing Wild On Merger, FDA News | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-19 12:15:19 | https://finance.yahoo.com/m/de82d955-19b6-3ecf-8ee4-e9cd0b8dab59/dow-jones-today%2C-futures.html | Target and Southwest Airlines staked early leads, Intel led the Dow, but stock futures struggled to hold Wednesday's narrow early gains. | Dow Jones Today, Futures Fight To Hold Gains; Target Heads Retail Rally; Gilead Swoons As FDA Balks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-19 10:54:16 | https://seekingalpha.com/article/4369700-retirees-dividend-portfolio-janes-july-update-resilient-dividends | Jane's retirement accounts generated a total of $2,028.65 of dividend income for July 2020 vs. $1,988.24 of dividend income for July of 2019. | The Retiree's Dividend Portfolio - Jane's July Update: Resilient Dividends | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-19 09:49:18 | https://seekingalpha.com/article/4369686-tracking-john-paulsons-paulson-company-portfolio-q2-2020-update | John Paulson’s 13F portfolio value increased from $2.62B to $3.13B this quarter. Paulson & Company's largest three positions are Bausch Health, Horizon Therapeutics, and SPDR Gold ETF. | Tracking John Paulson's Paulson & Company Portfolio - Q2 2020 Update | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-19 06:30:00 | https://seekingalpha.com/article/4369588-you-like-attractively-valued-blue-chips-love-7-dividend-growth-stocks | Top-quality blue-chip dividend growth stocks are one of the most effective ways of compounding both income and wealth over time. | If You Like Attractively Valued Blue-Chips, You'll Love These 7 Dividend Growth Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
benzinga | 2020-08-19 00:00:00 | https://www.benzinga.com/analyst-ratings/analyst-color/20/08/17156935/gilead-analysts-trim-expectations-after-very-unexpected-adverse-fda-ruling | Gilead Sciences, Inc. (NASDAQ: GILD) faces a regulatory setback as filgotinib, an investigational drug it is co-developing with GALAPAGOS NV/S ADR (NASDAQ: GLPG... | Gilead Analysts Trim Expectations After 'Very Unexpected' Adverse FDA Ruling | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-18 15:35:04 | https://seekingalpha.com/article/4369557-dividend-aristocrats-show-six-best-mid-august-selections | S&P 500® Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years.-- us.spindices.com. | Dividend Aristocrats Show Six Best Mid-August Selections | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-18 11:41:35 | https://finance.yahoo.com/news/u-activists-complain-virtual-shareholder-114135191.html | Justin Danhof has used annual shareholder meetings to question companies on social issues for the last nine years. This year, Danhof often found himself ignored, as companies held their shareholder meetings remotely during the COVID-19 pandemic, and asked investors to submit their questions online. Danhof said his qu... | U.S. activists complain that virtual shareholder meetings let companies silence them | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-18 09:37:12 | https://seekingalpha.com/article/4369444-abbvie-solid-5-yield-potential-for-growth | AbbVie is a major pharmaceutical that recently acquired Allergan to reduce their dependence on sales from their blockbuster therapeutic Humira due to expire in 2023. | AbbVie: A Solid 5% Yield With The Potential For Growth | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-17 21:02:12 | https://seekingalpha.com/article/4369357-abbvie-trifecta-of-yield-growth-and-total-return-potential | Since its spin-off from Abbott Laboratories in 2013, AbbVie has delivered strong dividend growth. AbbVie delivered 0.8% YoY revenue growth through H1 2020 and 8.2% YoY adjusted diluted EPS growth. | AbbVie: A Trifecta Of Yield, Growth, And Total Return Potential | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-17 11:34:12 | https://seekingalpha.com/article/4369185-3-reasons-abbvie-is-ready-to-bounce | Rinvoq a compelling blockbuster. Allergan tailwinds explained. | 3 Reasons AbbVie Is Ready To Bounce | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-16 10:42:00 | https://finance.yahoo.com/m/ec7492e8-bfd6-30b3-9c89-fe9ea7e6e560/3-dividend-stocks-yielding.html | Here are three dividend stocks yielding more than 4% that are safe buys right now. Brookfield Infrastructure Partners' (NYSE: BIP) dividend currently yields 4.4%. Brookfield Infrastructure, as its name indicates, owns and manages infrastructure assets. | 3 Dividend Stocks Yielding More Than 4% That Are Safe Buys Right Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-14 15:45:03 | https://finance.yahoo.com/news/abbvie-abbv-top-dividend-stock-154503552.html | Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out. | AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-14 15:29:03 | https://finance.yahoo.com/news/zacks-analyst-blog-highlights-home-152903382.html | The Zacks Analyst Blog Highlights: Home Depot, AbbVie, Broadcom, 3M and Morgan Stanley | The Zacks Analyst Blog Highlights: Home Depot, AbbVie, Broadcom, 3M and Morgan Stanley | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-14 10:00:00 | https://seekingalpha.com/article/4368089-motorhome-retirement-july-update-yellowstone | We continued our summer adventure with a trip to Yellowstone National Park. Income exceeded expenses for the month. | Motorhome Retirement: July Update - Yellowstone! | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-14 08:56:05 | https://seekingalpha.com/article/4368707-tracking-david-abrams-abrams-capital-management-portfolio-q2-2020-update | David Abrams' 13F portfolio value increased this quarter from $2.54B to $3.09B. The number of positions decreased from 22 to 20. | Tracking David Abrams' Abrams Capital Management Portfolio - Q2 2020 Update | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-14 06:30:00 | https://seekingalpha.com/article/4368593-investing-for-long-run-navigating-bifurcated-market | Current market moves may trap the long-term investor. The Great Reset Matrix is a helpful tool for keeping eyes on the future. | Investing For The Long Run: Navigating A Bifurcated Market | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-14 01:03:20 | https://seekingalpha.com/article/4368652-reader-favorites-and-rogues-july-8-to-august-7-peg-30-ripe-dividends-for-picking | July 6-August 7: Readers of Fredrik Arnold articles mentioned 50 equities in their comments. Some lamented bad news, so bad news investments (rogues) mixed with (mostly) favorites. | Reader Favorites And Rogues July 8 To August 7 Peg 30 Ripe Dividends For Picking | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-13 23:17:13 | https://finance.yahoo.com/news/david-abrams-sells-2-holdings-231713639.html | Klarman student releases portfolio Continue reading... | David Abrams Sells 2 Holdings, Drills Into Kinder Morgan in 2nd Quarter | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-13 17:17:05 | https://finance.yahoo.com/news/top-analyst-reports-home-depot-171705237.html | Top Analyst Reports for Home Depot, AbbVie & Broadcom | Top Analyst Reports for Home Depot, AbbVie & Broadcom | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-13 13:14:01 | https://finance.yahoo.com/news/abbvie-outperforms-large-cap-pharma-131401459.html | AbbVie's (ABBV) key drug, Humira is seeing strong demand in the United States while generics are eroding ex-U.S. sales. New drugs Skyrizi and Rinvoq are seeing strong sales uptake. | AbbVie Outperforms Large-Cap Pharma Industry Year to Date | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-13 09:36:41 | https://seekingalpha.com/article/4368306-genomic-medicine-summer-2020-update | FDA approvals, new guidance statements, and RMAT requests all show the pace of genomics is accelerating. | Genomic Medicine: Summer 2020 Update | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-12 23:03:08 | https://seekingalpha.com/article/4368201-tracking-tweedy-browne-portfolio-q2-2020-update | Tweedy Browne’s 13F portfolio value increased from $2.15B to $2.51B this quarter. The largest five individual stock positions are Alphabet, Berkshire Hathaway, Johnson & Johnson, Cisco Systems, and Baidu, and they account for ~55% of the portfolio. | Tracking Tweedy Browne Portfolio - Q2 2020 Update | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-12 21:45:00 | https://finance.yahoo.com/news/england-journal-medicine-publishes-positive-214500683.html | AbbVie (NYSE: ABBV) today announced the publication of results from the Phase 3 VIALE-A clinical study in patients with AML in the New England Journal of Medicine (NEJM). The study, which evaluated newly-diagnosed AML patients who had not yet been treated and were unable to tolerate traditional intensive chemotherapy, ... | New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-12 19:44:14 | https://finance.yahoo.com/news/tweedy-browne-adds-morgan-stanley-194414545.html | Firm reveals top trades of the 2nd quarter Continue reading... | Tweedy Browne Adds Morgan Stanley, AbbVie to Portfolio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha | 2020-08-11 17:36:42 | https://seekingalpha.com/article/4367582-abbvie-another-opportunity | AbbVie has dipped back to $92 following the COVID-19 hits to revenues. The company has already seen sales rebound close to normalized levels setting record pro-forma revenues in 2H. | AbbVie: Another Opportunity (NYSE:ABBV) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha | 2020-08-11 16:10:44 | https://seekingalpha.com/article/4367541-33-fit-dividend-stocks-for-times-august-assortment | Kiplinger listed five sets of dividend stocks qualified to survive the COVID-19 pandemic. Barron's weekly added one more. | 33 Fit Dividend Stocks For Our Times: The August Assortment | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha | 2020-08-10 14:21:18 | https://seekingalpha.com/article/4367042-nicholas-wards-dividend-growth-portfolio-july-2020-update | Disney's dividend suspension came back to bite me this month. However, year-to-date, my passive income is still up 10.5% compared to the first 7 months of 2019. | Nicholas Ward's Dividend Growth Portfolio: July 2020 Update | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-08-10 00:00:00 | https://www.businesswire.com/news/home/20200810005402/en/Analysis-Impact-COVID-19--Global-Hepatocellular-Carcinoma-Drugs | The Global Hepatocellular Carcinoma Drugs Market will grow by $ 85.10 mn during 2020-2024 | Analysis on Impact of COVID-19- Global Hepatocellular Carcinoma Drugs Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha | 2020-08-08 19:56:15 | https://seekingalpha.com/article/4366443-dividend-challenger-highlights-week-of-august-9 | A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends. | Dividend Challenger Highlights: Week Of August 9 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-07 16:24:20 | https://finance.yahoo.com/news/5-health-care-companies-outperforming-162420296.html | UnitedHealth on the list Continue reading... | 5 Health Care Companies Outperforming the Market | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-07 15:58:46 | https://finance.yahoo.com/news/3-high-yield-stock-picks-155846422.html | Their dividend yields beat that of the S&P 500 Continue reading... | 3 High Yield Stock Picks for the Dividend Investor | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-07 15:30:03 | https://finance.yahoo.com/news/pharma-stock-roundup-abbv-mrk-153003990.html | Sanofi (SNY)/Glaxo (GSK) and J&J (JNJ) sign deals with U.S. government for coronavirus vaccine candidate. Several drugmakers announce second-quarter results. | Pharma Stock Roundup: ABBV, MRK Q2 Earnings & Coronavirus Updates in Focus | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
abcnews | 2020-08-07 01:56:22 | https://abcnews.go.com/Business/wireStory/humira-maker-settle-california-lawsuit-24-million-72226569 | The maker of the drug Humira will pay $24 million to settle a California lawsuit that alleged it violated the state;s insurance fraud law | Humira maker to settle California lawsuit for $24 million | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
abcnews | 2020-08-07 01:56:17 | https://abcnews.go.com/Health/wireStory/humira-maker-settle-california-lawsuit-24-million-72226568 | The maker of the drug Humira will pay $24 million to settle a California lawsuit that alleged it violated the state;s insurance fraud law | Humira maker to settle California lawsuit for $24 million | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-06 17:42:51 | https://finance.yahoo.com/news/early-sales-eli-lillys-migraine-174251095.html | The company is confident Reyvow will reach $13 billion by 2027 Continue reading... | Early Sales of Eli Lilly's Migraine Drug Disappoint | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-08-06 00:00:00 | https://www.businesswire.com/news/home/20200806005444/en/PARP-Poly-ADP-Ribose-Polymerase-Inhibitors-Market-Analysis | The Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market will grow by USD 810.23 mn during 2020-2024 | PARP (Poly ADP-Ribose Polymerase) Inhibitors Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Expanded Application of PARP Inhibitors to Boost the Market Growth | Technavio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-04 23:44:11 | https://finance.yahoo.com/news/3-diverse-large-cap-stocks-234411816.html | Investors should consider adding a few large-cap names that are prepared to grow for years to come. These three stocks also pay dividends and provide exposure to three very different and vital industries... | 3 Diverse Large-Cap Stocks to Buy Now to Boost Your Long-Term Portfolio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.marketscreener.com | 2020-08-04 14:03:05 | https://www.marketscreener.com/ABBVIE-INC-12136589/news/ABBVIE-MANAGEMENT-S-DISCUSSION-AND-ANALYSIS-OF-FINANCIAL-CONDITION-AND-RESULTS-OF-OPERATIONS-form-31054010/ | ABBVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) | MarketScreener | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Yahoo | 2020-08-04 10:34:00 | https://finance.yahoo.com/m/ae2662f3-d78a-3839-9033-e769981c6a0e/how-neurocrine-biosciences.html | Neurocrine Biosciences' (NASDAQ: NBIX) 30% plunge earlier this year during the coronavirus-fueled market meltdown is practically all but forgotten now. Here's what you need to know about Neurocrine's impressive Q2 update. Neurocrine reported revenue of $302.4 million in the second quarter, a 65% increase from the $18... | How Neurocrine Biosciences Crushed It in Q2 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-08-04 00:00:00 | https://www.businesswire.com/news/home/20200804005069/en/COVID-19-Impacts-Antiviral-Drugs-Market-Accelerate-CAGR | The Global Antiviral Drugs Market will grow by USD 43.37 bn during 2020-2024 | COVID-19 Impacts: Antiviral Drugs Market Will Accelerate at a CAGR of Over 9% Through 2020-2024 | Growing Cases of Viral Infections to Boost Growth | Technavio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.marketscreener.com | 2020-08-03 20:13:12 | https://www.marketscreener.com/VOYAGER-THERAPEUTICS-INC-24872703/news/VOYAGER-THERAPEUTICS-INC-Termination-of-a-Material-Definitive-Agreement-form-8-K-31047760/ | VOYAGER THERAPEUTICS, INC. : Termination of a Material Definitive Agreement (form 8-K) | MarketScreener | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
marketwatch | 2020-08-03 19:31:00 | https://www.marketwatch.com/story/coronavirus-update-us-death-toll-climbs-toward-150000-as-covid-19-enters-dangerous-new-phase-2020-08-03 | The U.S. tally for new confirmed cases of the coronavirus that causes COVID-19 continued its march toward 5 million, with the death toll closing in on... | Coronavirus update: U.S. death toll climbs to 155,000, as COVID-19 enters ‘dangerous new phase’ | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
marketwatch | 2020-08-03 11:56:29 | https://www.marketwatch.com/story/abbvie-amgen-and-takeda-start-testing-drugs-as-covid-19-treatments-2020-08-03 | AbbVie Inc. undefined, Amgen Inc. undefined, and Takeda Pharmaceutical Co. Ltd. undefined announced they started enrolling patients in a clinical trial... | AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatments | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-03 11:56:00 | https://finance.yahoo.com/m/ec9fa9e4-b773-3a77-b1bb-13492a9ab276/abbvie%2C-amgen-and-takeda.html | AbbVie Inc. , Amgen Inc. , and Takeda Pharmaceutical Co. Ltd. announced they started enrolling patients in a clinical trial testing three of their drugs as treatments for severely ill and hospitalized COVID-19 patients. This includes the still investigational HIV therapy cenicriviroc, psoriasis medication Otezla, and ... | AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatments | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-03 11:30:00 | https://finance.yahoo.com/news/members-covid-r-d-alliance-113000960.html | Today, members of the COVID R&D Alliance AbbVie, Inc. (NYSE: ABBV), Amgen Inc. (NASDAQ: AMGN), and Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) announced the first patients enrolled in the I-SPY COVID Trial (Investigation of Serial Studies to Predict Your COVID Therapeutic Response with Biomarker Integration and Adaptive... | Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-03 11:29:34 | https://finance.yahoo.com/news/abbvie-inc-nyse-abbv-p-112934976.html | When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may... | AbbVie Inc.'s (NYSE:ABBV) P/E Is On The Mark | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-03 11:00:00 | https://finance.yahoo.com/m/dc874884-8fce-333e-b237-be3fd759760e/a-giant-pension-sold-apple.html | The New York State Teachers’ Retirement System trimmed investments in Apple and Intel stock in the second quarter. The pension also bought more Nvidia and AbbVie stock. | A Giant Pension Sold Apple and Intel Stock. Here Are Two Stocks It Bought. | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
wsj | 2020-08-03 09:30:00 | https://www.wsj.com/articles/nasdaq-indexes-lead-way-on-both-sides-of-atlantic-11596447000 | In the U.S., the stock-exchange operator’s indexes are the country’s best-performing major stock benchmarks this year. In Europe, the Nasdaq-owned Copenhagen exchange’s index is leading the charge. | Nasdaq Indexes Lead Way on Both Sides of Atlantic | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
investing | 2020-08-03 00:00:00 | https://www.investing.com/news/coronavirus/rival-drugmakers-launch-joint-trial-of-medicines-for-covid19-2250705 | Rival drugmakers launch joint trial of medicines for COVID-19 | Rival drugmakers launch joint trial of medicines for COVID-19 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-02 20:31:18 | https://finance.yahoo.com/news/market-continues-undervalue-abbvie-203118595.html | The stock trades with a single-digit multiple despite strong growth rates from products outside of Humira Continue reading... | The Market Continues to Undervalue AbbVie | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-02 13:07:00 | https://finance.yahoo.com/m/5ba3790c-dcca-33f4-8c68-79d1230bcbb4/2-stocks-to-supplement-your.html | According to data published by the U.S. Social Security Administration (SSA) in December 2019, the median monthly benefit paid out to retired individuals is just $1,503. The SSA estimates that approximately nine out of 10 persons aged 65 and up collect Social Security and anticipates paying more than $1 trillion to ro... | 2 Stocks to Supplement Your Social Security Income | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-08-02 11:20:57 | https://seekingalpha.com/article/4363620-gilead-perhaps-value-trap-no-longer | GILD sank back into its familiar pattern of disappointing the Street, selling off below $70 again after reporting Q2 results. | Gilead: Perhaps A Value Trap No Longer | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-08-01 00:32:53 | https://finance.yahoo.com/m/72e19094-2a74-319d-aa5f-082cb3eec319/abbvie-%28abbv%29-q2-2020.html | ABBV earnings call for the period ending June 30, 2020. | AbbVie (ABBV) Q2 2020 Earnings Call Transcript | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-31 20:33:13 | https://finance.yahoo.com/m/12c63847-eccb-34af-b14e-d1ff2a06eaf2/abbvie-earnings-top%2C-drug.html | AbbVie earnings and sales topped views. The drug giant raised full-year EPS targets including newly acquired Allergan. AbbVie stock rose into a buy area. | AbbVie Earnings Top, Drug Giant Rebounds Bullishly, Flashes Buy Signal | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-31 17:09:05 | https://finance.yahoo.com/news/abbvies-abbv-q2-earnings-revenues-170905443.html | AbbVie (ABBV) beats on second-quarter 2020 earnings and revenues. Shares up in pre-market trading. | AbbVie's (ABBV) Q2 Earnings and Revenues Beat Estimates | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-31 16:44:04 | https://finance.yahoo.com/news/pharma-stock-roundup-q2-earnings-164404921.html | Pfizer's (PFE) coronavirus vaccine candidate enters phase III. Several drugmakers announce second-quarter results. | Pharma Stock Roundup: Q2 Earnings & J&J and PFE's Coronavirus Updates in Focus | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-31 15:58:07 | https://seekingalpha.com/article/4363134-abbvie-inc-abbv-ceo-rick-gonzalez-on-q2-2020-results-earnings-call-transcript | AbbVie Inc. (NYSE:ABBV) Q2 2020 Earnings Conference Call July 31, 2020 9:00 AM ET Company Participants Liz Shea - Vice President, Investor Relations Rick Gonzalez - Chairman of the Board & Chief Executive Officer Michael Severino - Vice Chairman & President Rob Michael - Executive Vice President & Chief Fin... | AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q2 2020 Results - Earnings Call Transcript | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-31 15:54:00 | https://finance.yahoo.com/m/79c3c2ad-da0d-3c0a-9fc4-481f41673309/5-key-things-you%26%2339%3Bll-want.html | AbbVie (NYSE: ABBV) announced its second-quarter results before the market opened on Friday. How did AbbVie fare in its first quarterly results with Allergan under its wing? Here are five key things you'll want to know about AbbVie's Q2 update. | 5 Key Things You'll Want to Know About AbbVie's Q2 Update | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
marketwatch | 2020-07-31 15:28:00 | https://www.marketwatch.com/story/coronavirus-update-pandemic-will-continue-for-some-time-experts-tell-congress-as-us-case-tally-nears-45-million-2020-07-31 | With close to 4.5 million Americans confirmed to have been infected with the coronavirus illness COVID-19, the pandemic will continue for some time, public... | Coronavirus update: Pandemic will continue for some time, experts tell Congress as U.S. case tally nears 4.5 million | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://investorplace.com | 2020-07-31 15:10:07 | https://investorplace.com/2020/07/abbvie-earnings-abbv-stock-drops-2-despite-q2-beats/ | AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street. | AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-31 14:31:00 | https://finance.yahoo.com/m/1db7f2ef-1358-3ed4-b754-cce856ed63f4/let%26%2339%3Bs-not-overlook.html | Apple and Amazon have stolen the show. As a matter of fact, even though this name was one of my picks for the coming year in late 2019, I really have not focused on it as much since the early May closing of the Allergan acquisition. AbbVie reported on Friday morning. | Let's Not Overlook AbbVie's Q2 Beat | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
barrons | 2020-07-31 14:26:00 | https://www.barrons.com/articles/abbvie-beats-earnings-expectations-but-stock-falls-anyway-51596205604 | The drug company beat Wall Street earnings estimates for the second quarter but issued guidance for the full year that fell below analyst expectations. | AbbVie Beats Earnings Expectations but Stock Falls Anyway | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.marketscreener.com | 2020-07-31 12:45:14 | https://www.marketscreener.com/ABBVIE-INC-12136589/news/ABBVIE-INC-Results-of-Operations-and-Financial-Condition-Financial-Statements-and-Exhibits-form-31030838/ | ABBVIE INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) | MarketScreener | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
benzinga | 2020-07-31 00:00:00 | https://www.benzinga.com/news/earnings/20/07/16868143/earnings-scheduled-for-july-31-2020 | Companies Reporting Before The Bell
• Chevron Inc. (NYSE:CVX) is expected to report quarterly loss at $0.92 per share on revenue of $22.10 billion.
• Weyerhaeuser Inc. (... | Earnings Scheduled For July 31, 2020 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-30 04:08:44 | https://seekingalpha.com/article/4362149-3-low-beta-blue-chips-high-dividend-yields | During volatile times, low-beta stocks are a welcome sight as they can provide stability to the portfolio. | 3 Low-Beta Blue Chips With High Dividend Yields | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-27 15:58:10 | https://seekingalpha.com/article/4361121-retirees-dividend-portfolio-janes-june-update-record-dividends-during-covidminus-19 | Jane's retirement accounts generated a total of $2,047.11 of dividend income for June 2020 vs. $1,561.04 of dividend income for June of 2019. | The Retiree's Dividend Portfolio - Jane's June Update: Record Dividends During COVID-19 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-27 15:22:41 | https://www.thelincolnianonline.com/2020/07/27/resource-management-llc-sells-299-shares-of-abbvie-inc-nyseabbv.html | Resource Management LLC lowered its position in shares of AbbVie Inc (NYSE:ABBV) by 5.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,634 shares of the company’s stock after selling 299 shares during the quarter. Resource Manag... | Resource Management LLC Sells 299 Shares of AbbVie Inc (NYSE:ABBV) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-27 15:22:40 | https://www.thelincolnianonline.com/2020/07/27/palisade-asset-management-llc-decreases-stock-holdings-in-abbvie-inc-nyseabbv.html | Palisade Asset Management LLC decreased its position in shares of AbbVie Inc (NYSE:ABBV) by 19.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,326 shares of the company’s stock after selling 14,530 shares during the qu... | Palisade Asset Management LLC Decreases Stock Holdings in AbbVie Inc (NYSE:ABBV) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-27 14:12:41 | https://www.thelincolnianonline.com/2020/07/27/abbvie-inc-nyseabbv-shares-acquired-by-selway-asset-management.html | Selway Asset Management increased its holdings in shares of AbbVie Inc (NYSE:ABBV) by 0.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 33,290 shares of the company’s stock after purchasing an additional 175 shares during the perio... | AbbVie Inc (NYSE:ABBV) Shares Acquired by Selway Asset Management | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-27 13:36:41 | https://www.thelincolnianonline.com/2020/07/27/sumitomo-mitsui-trust-holdings-inc-has-794-81-million-holdings-in-abbvie-inc-nyseabbv.html | Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of AbbVie Inc (NYSE:ABBV) by 24.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,194,271 shares of the company’s stock after purchasing an additional 1,630,022 ... | Sumitomo Mitsui Trust Holdings Inc. Has $794.81 Million Holdings in AbbVie Inc (NYSE:ABBV) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-27 10:38:41 | https://www.thelincolnianonline.com/2020/07/27/grandfield-dodd-llc-buys-275-shares-of-abbvie-inc-nyseabbv.html | Grandfield & Dodd LLC raised its holdings in AbbVie Inc (NYSE:ABBV) by 5.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,562 shares of the company’s stock after buying an additional 275 shares during the quarter. Grandfield & Dodd LLC’s holdings in Abb... | Grandfield & Dodd LLC Buys 275 Shares of AbbVie Inc (NYSE:ABBV) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-27 10:02:42 | https://www.thelincolnianonline.com/2020/07/27/rothschild-investment-corp-il-acquires-406-shares-of-abbvie-inc-nyseabbv.html | Rothschild Investment Corp IL lifted its stake in AbbVie Inc (NYSE:ABBV) by 0.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 206,349 shares of the company’s stock after buying an additional 406 shares during the quarter. AbbVie makes up 2.... | Rothschild Investment Corp IL Acquires 406 Shares of AbbVie Inc (NYSE:ABBV) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-27 07:54:06 | https://seekingalpha.com/article/4360958-vanguard-health-care-etf-outlook-remains-favorable-despite-higher-valuation | VHT invests in large-cap U.S. healthcare stocks. | Vanguard Health Care ETF: Outlook Remains Favorable Despite Higher Valuation | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-27 05:53:23 | https://seekingalpha.com/article/4360931-14-best-high-yield-dividend-aristocrats-retirees-can-safely-buy-right-now | The broader market is 36% historically overvalued, and short-term correction risk is high. But no matter how irrational a market bubble, quality blue-chips are always on sale. | The 14 Best High-Yield Dividend Aristocrats Retirees Can Safely Buy Right Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
businesswire | 2020-07-27 00:00:00 | https://www.businesswire.com/news/home/20200727005428/en/Global-Hypertriglyceridemia-Therapeutics-Market-Generate-Revenue-12863.1 | The North America hypertriglyceridemia therapeutics market is estimated to be the most lucrative during the period of forecast. | Global Hypertriglyceridemia Therapeutics Market to Generate Revenue of US$ 12,863.1 Million by end of 2027, Says Coherent Market Insights | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
benzinga | 2020-07-26 00:00:00 | https://www.benzinga.com/general/biotech/20/07/16778963/the-week-ahead-in-biotech-spotlight-on-gw-pharma-ultragenyx-fda-decisions-pfizer-earnings | Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from... | The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-24 15:21:33 | https://seekingalpha.com/article/4360703-rising-risk-what-you-can-buy | Volatility caused by dismal economic data creates opportunities. Our overbought reading is heating up, suggesting you proactively pick entry points. | Rising Risk? Here's What You Can Buy | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-22 15:05:51 | https://seekingalpha.com/article/4359952-3-reasons-you-should-buy-abbvie | Selling delayed AbbVie's upward run to hold $100. Atopic dermatitis drug a positive catalyst. | 3 Reasons You Should Buy AbbVie | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-22 10:00:14 | https://seekingalpha.com/article/4359830-motorhome-retirement-june-update-finally-off-to-black-hills | We finally got to get out and enjoy some the wonders the United States has to offer. We visited the Black Hills National Forest and the Badlands National Park. | Motorhome Retirement: June Update, Finally Off To The Black Hills | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-22 01:07:29 | https://seekingalpha.com/article/4359790-sand-in-shoes-carnage-and-recovery | The volatility in the markets seems to have settled down in the past month, and I feel comfortable writing an update article again. | Sand In My Shoes - Carnage And Recovery | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-21 05:27:50 | https://seekingalpha.com/article/4359528-dividend-aristocrats-flaunt-7-surefire-august-selections | S&P 500® Dividend Aristocrats measure performance of S&P 500 companies that have increased dividends every year for 25 consecutive years.---us.spindices.com. | Dividend Aristocrats Flaunt 7 Surefire August Selections | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-19 02:10:41 | https://www.thelincolnianonline.com/2020/07/19/abbvie-nyseabbv-reaches-new-1-year-high-at-100-86.html | AbbVie Inc (NYSE:ABBV)’s stock price hit a new 52-week high during mid-day trading on Friday . The company traded as high as $100.86 and last traded at $100.42, with a volume of 106159 shares changing hands. The stock had previously closed at $99.92. A number of analysts have recently weighed in on ABBV shares. Royal [... | AbbVie (NYSE:ABBV) Reaches New 1-Year High at $100.86 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha | 2020-07-18 13:00:00 | https://seekingalpha.com/insight/investing-strategy/article/4358859-how-to-fully-benefit-from-insider-information-3-dos-and-donts | Insider trades are very informative to include in your investment strategy as insiders know their business better than anyone else. | How To Fully Benefit From Insider Trading Information: 3 Do's And Don'ts | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-18 09:29:00 | https://seekingalpha.com/article/4358852-passive-dgi-core-portfolio-retirement-strategy-allows-you-to-sleep-well | We believe a well thought-out DGI strategy provides almost everything that most retirees and conservative investors would need: Decent income, relative safety, and reasonable growth. | The Passive DGI Core Portfolio: Retirement Strategy That Allows You To Sleep Well | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-18 09:00:00 | https://seekingalpha.com/article/4358859-how-to-fully-benefit-from-insider-information-3-dos-and-donts | Insider trades are very informative to include in your investment strategy as insiders know their business better than anyone else. | How To Fully Benefit From Insider Information: 3 Do's And Don'ts | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
https://www.thelincolnianonline.com | 2020-07-18 01:50:41 | https://www.thelincolnianonline.com/2020/07/18/10-06-billion-in-sales-expected-for-abbvie-inc-nyseabbv-this-quarter.html | Equities analysts expect that AbbVie Inc (NYSE:ABBV) will post $10.06 billion in sales for the current quarter, according to Zacks. Two analysts have made estimates for AbbVie’s earnings, with the lowest sales estimate coming in at $9.90 billion and the highest estimate coming in at $10.21 billion. AbbVie posted sales ... | $10.06 Billion in Sales Expected for AbbVie Inc (NYSE:ABBV) This Quarter | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-17 14:24:02 | https://finance.yahoo.com/news/j-j-sets-motion-pharma-142402649.html | Investors typically look at J&J;'s (JNJ) results for signals about how the rest of the big drugmakers will fare. | J&J Sets in Motion Pharma Q2 Earnings: 3 Stocks to Buy | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-17 14:17:33 | https://seekingalpha.com/article/4359100-top-stocks-to-buy-now | Top Stocks To Buy Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
seekingalpha.com | 2020-07-17 11:45:00 | https://seekingalpha.com/article/4359054-distillate-capital-partners-q2-2020-investment-letter | Distillate Capital Partners was formed in 2017 and is based in Chicago, IL. The fund strategies use cash-flow-based measures of value and quality that are designed to avoid accounting distortions that we believe have rendered many traditional metrics less relevant in an increasingly asset-light world. | Distillate Capital Partners Q2 2020 Investment Letter | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-17 10:43:00 | https://finance.yahoo.com/m/cc50dc11-63fc-3d1d-a34e-afdd604a9f4f/these-3-stocks-are-still.html | AbbVie (NYSE: ABBV) shares are up more than 20% in the last three months. There's one obvious reason why AbbVie sports such a cheap valuation. More importantly, AbbVie has other arrows in its quiver that will help offset future sales declines for Humira, notable among them new immunology drugs Rinvoq and Skyrizi, and... | These 3 Stocks Are Still Ridiculously Cheap Right Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-16 22:22:35 | https://finance.yahoo.com/news/pharmas-seeking-overcome-patent-expirations-222235774.html | Takeda, Amgen among those losing exclusivity on key drugs Continue reading... | Pharmas Seeking to Overcome Patent Expirations | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-16 15:50:03 | https://finance.yahoo.com/news/value-investors-buy-abbvie-abbv-155003285.html | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Should Value Investors Buy AbbVie (ABBV) Stock? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-15 19:04:02 | https://seekingalpha.com/article/4358714-cath-what-catholic-s-and-p-500-etf-excludes-vs-overweights | The Global X S&P 500 Catholic Values Index ETF is the largest US-listed faith-based ETF, applying the ESG process of the United States Conference of Catholic Bishops. | CATH: What The 'Catholic S&P 500' ETF Excludes Vs. Overweights | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-15 15:47:27 | https://seekingalpha.com/article/4358678-eli-lilly-upside-momentum-fading-fast | Eli Lilly's valuation is stretched and financial leverage is high, both risks if operating results falter. | Eli Lilly: Upside Momentum Fading Fast | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-07-15 12:40:53 | https://finance.yahoo.com/news/researchers-abbvies-tricor-reduced-severity-124053251.html | AbbVie Inc (NYSE: ABBV) shares popped Tuesday after researchers found that the large-cap pharma's cholesterol-lowering drug Tricor could work against SARS-CoV2, the virus that causes COVID-19.What Happened: Researchers at Israel's Hebrew University and the Mount Sinai Medical Center in New York said FDA-approved Trico... | Researchers Say AbbVie's Tricor Reduced Severity Of COVID-19 Into 'Nothing Worse Than A Common Cold' | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-15 07:00:00 | https://seekingalpha.com/article/4358218-s-and-p-500-buybacks-104-billion-of-equity-converted-to-104-billion-of-debt-risky-business | In the past five years, the number of technically-insolvent companies in the S&P 500 has more than tripled, primarily due to share buybacks funded with debt. | S&P 500: Buybacks - $104 Billion Of Equity Converted To $104 Billion Of Debt - Risky Business | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-15 05:28:10 | https://seekingalpha.com/article/4358532-in-search-of-best-high-yield-opportunities-in-market-today | I sold my Dominion Energy stock on Monday morning and now I need to replace that lost income. I discuss now active management can bolster passive income strategies. | In Search Of The Best High-Yield Opportunities In The Market Today | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-07-21 10:43:01 | https://www.zacks.com/stock/news/2125294/amerisourcebergen-corporation-abc-soars-to-52-week-high-time-to-cash-out | AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. | AmerisourceBergen Corporation (ABC) Soars to 52-Week High, Time to Cash Out? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-07-20 18:10:03 | https://www.zacks.com/stock/news/2124965/hunting-for-growth-mixed-with-value-buy-these-3-stocks-now | Looking at three highly-ranked Zacks stocks that have outperformed the market over the last several years, while posting solid growth. All three stocks we dig into also offer investors great value at the moment. | Hunting for Growth Mixed with Value: Buy These 3 Stocks Now | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.